Matinas Biopharma Holdings Inc.
Organization details
- Legal name
- Matinas Biopharma Holdings Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Bedminster
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MTNB
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001582554
- EIN
- 46-3011414
Board of directors
-
An Evelyn D. · DirectorSince 2025
-
Edward Neugeboren · DirectorSince 2025
-
Eric J. Ende · DirectorSince 2023
-
Herbert J. Conrad · DirectorSince 2023
-
James S. Scibetta · DirectorSince 2023
-
Jerome D. Jabbour · Director · President and CEOSince 2023
-
Kathryn Penkus Corzo · DirectorSince 2023
-
Keith Murphy · DirectorSince 2025
-
Matthew Wikler · DirectorSince 2023
-
Natasha Giordano · DirectorSince 2023
-
Robin L. Smith · DirectorSince 2025
Chief executives
Director election results
Annual meeting of June 23, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.8%
-
99.3%
-
99.3%
-
99.3%
Board connections
8 of this board's directors also sit on 8 other boards. 7 are in the same sector.
- via An Evelyn D.
-
Celldex Therapeutics Inc. Same sectorvia Herbert J. Conrad
-
Celularity Inc. Same sectorvia Robin L. Smith
-
Grace Therapeutics Inc. Same sectorvia Edward Neugeboren
-
Indaptus Therapeutics Inc. Same sectorvia Jerome D. Jabbour
-
Marker Therapeutics Inc. Same sectorvia Kathryn Penkus Corzo
-
Oragenics Inc. Same sectorvia Natasha Giordano
-
VivoSim Labs Inc. Same sectorvia Keith Murphy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Adam K. Stern 10% owner | In-the-money exercise | +344,710 | $0.35 | $120,649 |
| Jul 10, 2026 | Adam K. Stern 10% owner | In-the-money exercise | +630,335 | $0.35 | $220,617 |
| Oct 31, 2025 | Adam K. Stern 10% owner | In-the-money exercise | +92,100 | $0.64 | $58,944 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Matinas Biopharma Holdings Inc.
Who is the CEO of Matinas Biopharma Holdings Inc.?
Jerome D. Jabbour is Matinas Biopharma Holdings Inc.'s President and CEO.
How many directors are on Matinas Biopharma Holdings Inc.'s board?
Matinas Biopharma Holdings Inc.'s board has 11 directors: An Evelyn D., Edward Neugeboren, Eric J. Ende, Herbert J. Conrad, James S. Scibetta, Jerome D. Jabbour, Kathryn Penkus Corzo, Keith Murphy, Matthew Wikler, Natasha Giordano and 1 other.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="matinas-biopharma-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.